Why Akso Health Group’s (AHG) Stock Is Up 5.88%
As of Friday, October 02, Akso Health Group’s AHG share price has surged by 5.88%, which has investors questioning if this is right time to sell.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People’s Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as trading and technological promotion services and import and export. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.
Commentary & Analysis
Why Akso Health Group’s (AHG) Stock Is Down 7.79%
As of Thursday, October 01, Akso Health Group’s AHG share price has dipped by 7.79%, which has investors questioning if this is right time to buy.Michael Rose
Why Akso Health Group’s (AHG) Stock Is Up 8.54%
As of Wednesday, September 30, Akso Health Group’s AHG share price has surged by 8.54%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why Akso Health Group’s (AHG) Stock Is Up 14.33%
As of Wednesday, September 30, Akso Health Group’s AHG share price has surged by 14.33%, which has investors questioning if this is right time to sell.Omar Beirat
Why Akso Health Group’s (AHG) Stock Is Up 5.20%
As of Tuesday, September 29, Akso Health Group’s AHG share price has surged by 5.20%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Financial Summary
| Share Statistics | AHG | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $985.2 | $1,687.3 | 46% |
|
| Shares Out (Mil) | 856.3 | 77.7 | 93% |
|
| Institutional Ownership | na | 87.7% | na |
|
| Float (Mil) | 854.0 | 56.1 | 90% |
|
| Beta | -1.00 | 0.81 | 1% |
|
| Avg Daily Volume (000s) | 607 | 614 | 60% |
|
| Price Change (52-week) |
(34.1%) | 76.5% | 26% |
|
| Growth | AHG | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 10.6% | na |
|
| Net Income (5yr) | 11.7% | (0.3%) | 58% |
|
| EPS (5yr) | 57.4% | 3.0% | 95 |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | (23.9%) | (17.3%) | 27% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | AHG | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $14 | $1,505 | 11% |
|
| Net Income (TTM) (Mil) | ($19) | $26 | 24% |
|
| EPS (TTM) | ($0.026) | $0.200 | 38% |
|
| Operating Cash Flow (TTM) (Mil) | ($13) | $157 | 18% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $374 | 0% |
|
| Enterprise Value (Q1) (Mil) | $1,253 | $2,284 | 43% |
|
| Valuation | AHG | Industry Median |
Percentile (All Stocks) |
|
| P/B | 5.48 | 2.90 | 81% |
|
| P/E | na | 25.2 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | AHG | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | (0.1%) | 27.6% | 4% |
|
| Net Margin | (135.0%) | 1.2% | 6% |
|
| ROA | (9.2%) | 2.1% | 26% |
|
| ROE | (9.8%) | 6.9% | 28% |
|
| Liabilities to Assets | 4.6% | 60.8% | 2% |
|
| F-Score | 4 | 5 | 33% |
|
Akso Health Group did not pass any screens on 10/2/2026.
